Fund Holdings — Octagon Capital Advisors LP

Total Portfolio Value:
$666.93M
Total Bought:
$235.40M
Total Sold:
$219.84M
Net Transaction:
+$15.56M
Notable People:
Ting (Nmn) Jia, Octagon Capital Advisors, Llc
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Syndax Pharmaceuticals, Inc.W EXP 02 10 202(SNDX)904,00027,330,800+26,426,800$11.95M$48.10M7.21%+$36.15M
Nuvation Bio Inc.W EXP 02 10 202(NUVB)312,33627,330,800+27,018,464$830.8K$48.10M7.21%+$47.27M
Apellis Pharmaceuticals Inc
COM
3,006,9802,094,000-912,980$95.95M$45.80M6.87%-$50.16M
Dianthus Therapeutics, Inc.(DNTH)2,110,1672,341,667+231,500$46.00M$42.48M6.37%-$3.52M
ArriVent BioPharma, Inc.(AVBP)2,059,3872,059,3870$54.86M$38.08M5.71%-$16.78M
Trevi Therapeutics, Inc.(TRVI)03,322,000+3,322,000$0$20.90M3.13%+$20.90M
Centessa Pharmaceuticals PlcADS1,993,0521,425,000-568,052$33.38M$20.49M3.07%-$12.89M
Gossamer Bio, Inc.ADS(GOSS)18,350,0001,425,000-16,925,000$16.60M$20.49M3.07%+$3.89M
Gossamer Bio, Inc.(GOSS)18,350,00018,350,0000$16.60M$20.18M3.03%+$3.59M
Ocular Therapeutix, Inc.(OCUL)2,425,0002,425,0000$20.71M$17.78M2.67%-$2.93M
Mind Medicine Mindmed Inc3,018,0003,018,0000$21.01M$17.66M2.65%-$3.35M
Cogent Biosciences, Inc.(COGT)2,763,0002,763,0000$21.55M$16.55M2.48%-$5.00M
Kalvista Pharmaceuticals Inc1,370,0001,370,0000$11.60M$15.81M2.37%+$4.21M
Taysha Gene Therapies, Inc.(TSHA)10,450,00010,700,000+250,000$18.08M$14.87M2.23%-$3.21M
Taysha Gene Therapies Inc010,700,000+10,700,000$0$14.87M2.23%+$14.87M
Scholar Rock Holding CorporationCL A(SRRK)488,0007,900,000+7,412,000$21.09M$13.90M2.08%-$7.19M
Nuvation Bio Inc.CL A(NUVB)9,202,9077,900,000-1,302,907$24.48M$13.90M2.08%-$10.58M
Humacyte, Inc.ADS(HUMA)0217,264+217,264$0$13.79M2.07%+$13.79M
Verona Pharma PlcADS571,264217,264-354,000$26.53M$13.79M2.07%-$12.74M
Tourmaline Bio Inc0905,000+905,000$0$13.77M2.06%+$13.77M
Merus N V308,000308,0000$12.95M$12.96M1.94%+$12.3K
Pharvaris N V
COM
778,000769,815-8,185$14.91M$12.09M1.81%-$2.83M
MoonLake ImmunotherapeuticsCL A(MLTX)0296,000+296,000$0$11.56M1.73%+$11.56M
Ocular Therapeutix, Inc.CL A(OCUL)2,425,000296,000-2,129,000$20.71M$11.56M1.73%-$9.14M
Syndax Pharmaceuticals, Inc.(SNDX)904,000904,0000$11.95M$11.11M1.67%-$845.2K
Atyr Pharma Inc900,0003,552,000+2,652,000$3.26M$10.73M1.61%+$7.47M
Scholar Rock Holding Corp571,264329,000-242,264$26.53M$10.58M1.59%-$15.95M
Scholar Rock Holding Corporation(SRRK)488,000329,000-159,000$21.09M$10.58M1.59%-$10.51M
Verastem, Inc.(VSTM)01,720,000+1,720,000$0$10.37M1.56%+$10.37M
ImmunityBio, Inc.(IBRX)01,720,000+1,720,000$0$10.37M1.56%+$10.37M
Regulus Therapeutics Inc4,848,8024,637,076-211,726$7.66M$8.11M1.22%+$453.8K
ARS Pharmaceuticals, Inc.(SPRY)0625,000+625,000$0$7.86M1.18%+$7.86M
ABIVAX Société AnonymeADS(ABVX)01,230,000+1,230,000$0$7.69M1.15%+$7.69M
Erasca, Inc.(ERAS)5,136,7955,136,7950$12.89M$7.04M1.06%-$5.86M
Viridian Therapeutics, Inc.(VRDN)870,000450,000-420,000$16.68M$6.07M0.91%-$10.61M
Capricor Therapeutics, Inc.(CAPR)0450,000+450,000$0$6.07M0.91%+$6.07M
Corbus Pharmaceuticals Holdings, Inc.(CRBP)1,115,0001,115,0000$13.16M$5.92M0.89%-$7.24M
Unicycive Therapeutics Inc10,000,00010,000,0000$7.94M$5.75M0.86%-$2.19M
Maze Therapeutics, Inc.(MAZE)0468,000+468,000$0$5.15M0.77%+$5.15M
Nuvation Bio Inc.(NUVB)312,336468,000+155,664$830.8K$5.15M0.77%+$4.32M
Perspective Therapeutics, Inc.(CATX)2,304,7522,250,000-54,752$7.35M$4.79M0.72%-$2.56M
Kalaris Therapeutics, Inc.(KLRS)0481,000+481,000$0$3.86M0.58%+$3.86M
Nuvation Bio Inc.(NUVB)9,202,907481,000-8,721,907$24.48M$3.86M0.58%-$20.62M
Neurogene Inc.(NGNE)303,000303,0000$6.93M$3.55M0.53%-$3.38M
Helix Acquisition Corp IiCL A250,000250,0000$2.63M$2.83M0.42%+$200.0K
Allovir Inc11,215,0000-11,215,000$4.71M$0—-$4.71M
BridgeBio Pharma, Inc.(BBIO)441,6000-441,600$12.12M$0—-$12.12M
Dyne Therapeutics, Inc.(DYN)668,0000-668,000$15.74M$0—-$15.74M
Insmed Incorporated(INSM)332,0000-332,000$22.92M$0—-$22.92M
Mersana Therapeutics Inc992,0000-992,000$1.42M$0—-$1.42M
Page 1 of 1
Octagon Capital Advisors LP — 13F Holdings — Q1 2025 | TickerTrail